TotalMarketCap

Kailera Therapeutics

KLRANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.582 B

$12.18 -4.84%

Close of 6 Nov 2026

As of 6 Nov 2026, Kailera Therapeutics (KLRA) has a market capitalization of $1.58B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

129,850,481

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #108SELLAS Life Sciences GroupSLS$1.59B
  2. #109Ultragenyx PharmaceuticalRARE$1.58B
  3. #110Kailera TherapeuticsKLRA$1.58B
  4. #111Braveheart BioBRVE$1.57B
  5. #112NanobiotixNBTX$1.52B

What if Kailera Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$217,456.83

Per share 17,854× higher

Bitcoin $1.53T

$11,766.21

Per share 966× higher

Apple $5.02T

$38,627.37

Per share 3,171× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Kailera Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.